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Abstract This paper focuses on innovation performance 
and investigates the impact of clusters, or localized 
networks involving industrial, academic and institutional 
players, in the pharmaceutical setting; we aim to enrich 
the line of inquiry into cluster-based innovation by 
applying a social network analysis (SNA) approach. The 
cluster concept has been defined in ambiguous ways, 
corresponding to a large variety of spatial and 
organizational concrete configurations. By analysing the 
U.S. pharmaceutical context, we show the structural and 
nodal network characteristics of the clusters and we shed 
some light on the "small-world" effects of the structural 
holes. 
 
Keywords Cluster, Innovation, Networks, Pharmaceutical 
Industry. 
                                         
1. Introduction 
 
With the growth of cooperative forms of management, 
positive perspectives on cooperation have, over the 
last decade, enjoyed a notable revival, especially when 
compared to the dominant strength of the competitive 
model as a paradigm of resource allocation efficiency 
[1]. The high level of competition in the business 
environment pushes firms towards new learning 
models based on the high value of relationship 
patterns: firms interact to successfully learn from one 
another [2]. Moreover, innovation is increasingly 
recognized as requiring the convergence of many 
sources of knowledge and skills, usually linked 
through a network [3]. 
 
Therefore, since the late 1980s, the rate of inter-
organizational alliances, or voluntary agreements 
between firms involving the exchange, sharing, or 
codevelopment of products, technologies, or services, has 
accelerated in multiple industries [4]. 
 
This situation is particularly true in an R&D intensive 
sector such as the pharmaceutical industry, where 
innovation is perhaps the most relevant performance 
driver. The pharmaceutical industry is characterized by 
the growing phenomenon of alliances and mergers and 
acquisitions (M&A)—both of which are strategic paths to 
increased reliance on external sources in a vertical de-
integration process—due to some remarkable tendencies. 
These are mainly connected to R&D activities and 
reflected in increased regulatory constraints and 
technological complexity.  
 
Some authors have suggested that the industry is facing a 
crisis that threatens the established model [5] and some 
tensions in the business model have begun to emerge.  
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In fact the dynamic and uncertain scenarios that 
economic organizations have to face force them to deeply 
rethink themselves and their structure through an 
internal innovation process aimed at making them more 
reactive and proactive, often through networks of 
informal relationships [6]. 
 
Several factors are contributing to a crisis in the R&D 
area, such as the continuous change in the process of 
drug discovery and development, the cost containment 
policies of institutions, the increasingly stringent 
requirements for the approval of new drugs resulting in 
more costly, long, internationally-based R&D activities 
[7], the growing number of patent expirations on 
blockbuster drugs, the enhanced competition from 
generic drugs, the growing importance of emergent 
countries [5], and an increase in the percentage of failures 
or non-completions in the R&D process.  
 
At the same time, the crisis in the productivity of 
pharmaceutical R&D organizations, as opposed to the 
positive results produced by biotechnology R&D, is 
leading to the development of bio-pharmaceutical firms 
[8], in which biotechnological opportunities are 
integrated with pharmaceutical ones. 
 
All these elements are forcing the industry to make 
adjustments to established patterns: pharmaceutical 
companies are searching for new, more efficient ways of 
managing the drug development process, while 
maintaining the process’s ethical integrity through M&A, 
in-licensing, alliances, new organizational and decisional 
structures of R&D, and outsourcing that are changing the 
traditional model of vertical integration of the 
pharmaceutical industry.  
 
Outsourcing practices, widely applied and boosted by 
the rush of corporate downsizing as an alternative to 
divestiture [9], have varied over the years, covering a 
diverse range of services from support activities to core 
managerial processes and from service-based activities 
to productive processes, such as modular production 
[10]. In knowledge-intensive industries (e.g., 
pharmaceutics, biochemistry, and healthcare), selective 
outsourcing usually occurs in favour of specialized and 
focused suppliers [11]. In fact, contract research 
organizations have become a fundamental component 
of R&D.  
 
In the end, a pharmaceutical firm cannot exist without 
networking in the scientific community: the amount of 
resources and knowledge needed for R&D has become 
overwhelming for a single organization; technological 
and market uncertainties foster the search for new 
opportunities; and performing R&D activities in 
networks can produce extra value for the participants 
and for innovation outcomes [12]. From an 
organizational point of view, not only the managerial 
components of R&D but also patent, regulatory, and 
commercial aspects are involved in all stages of R&D 
[8]. 
 
2. Research Problem 
 
Starting from these premises, the aim of the paper is to 
investigate a specific form of alliance, the cluster, in the 
setting of the pharmaceutical industry and its impact on 
innovation. Clusters have become a prevalent form of 
industrial organization and their innovativeness is 
considered to be a key source of regional and national 
competitive advantage.  
 
The work tries to enrich the line of inquiry into cluster-
based innovation by studying the effects of networks on 
clinical research. 
 
Clusters are localized networks [13], territorial 
aggregations of different players, that usually arise 
when business segments require high levels of 
specialization from multiple contributors [14]. They can 
have a more or less formalized structure, and, in any 
case, they assume a network configuration through 
contractual mechanisms.  
 
The cluster we analyse involves a public, an industrial 
and an academic player, which, in the pharmaceutical 
industry, typically comprise pharmaceutical firms, 
biotech firms, universities, research centres, and 
healthcare organizations such as hospitals, clinics, and 
healthcare institutions.  
 
As for the relevance of the topic, it is grounded in reality 
because the cluster meets two specificities of the 
pharmaceutical industry: (1) it is a highly regulated 
R&D setting. The pharmaceutical R&D process is 
organized as a strict sequence of different stages that are 
better performed through the involvement of different 
players assuming different roles in the healthcare value 
chain (e.g., research, manufacturing, provision of care, 
and regulation). In such a context, organizations often 
decide to work on a multiplayer basis in order to speed 
up the multistage process of pharmaceutical research 
through the sharing of scientific knowledge and the 
division of labour and the inclusion of patients in 
clinical trials to foster enrolment and the fulfilment of 
protocols. 
 
(2) Interactions between complementary players are 
needed for innovation. Firms must deal with the new 
systemic dimensions of technology and research. The 
strength of the cluster in the pharmaceutical industry can 
be said to rest upon the fact that research is built on three 
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pillars: basic academic research, corporate R&D, and 
clinical R&D. Diverse actors contribute together to these 
three crucial elements. 
 
Since pharmaceutical clusters are composed of players who 
have different roles in the value chain, operating in a 
pharmaceutical R&D process, we can presume that it is very 
likely that each player in the cluster has ties with similar 
organizations (with the same role in the value chain) that are 
however involved in other clusters. This assumption has 
driven us to the small world concept - highly dense clusters or 
hubs randomly connected to other clusters or hubs by weak 
ties in a sparse structure. The reference to this kind of 
structure allows us to enrich the literature on clusters and 
networks theoretically in many respects.  
 
As for the literature on clusters, we can analyse 
simultaneously intra-cluster and inter-cluster network 
characteristics and their impact on the cluster's innovative 
performance, overcoming the limits of the absence of 
significant contributions examining clusters of clusters, 
and we do this by using constructs and concepts derived 
from SNA.  
 
As for the literature on networks, we contribute to the 
debate on the network structure most beneficial for 
innovation. A small world network structure could provide 
an intermediate solution between sparse and dense 
structures that are complementary, through the 
distinction between intra-cluster and inter-cluster 
dynamics, and trying to establish its connection to 
innovation output would be a useful contribution to the 
abovementioned debate. 
 
The paper examines the impact of small world 
characteristics in the network structure on the network’s 
innovative performance. The aim is to analyse some 
principles of small world networks as conceptualized by 
reference [15] applying them in the context of U.S. 
pharmaceutical clusters and trying to identify their 
connection with network innovative outcomes. 
 
Finally we go further and enrich the small world network 
model by considering not just the structural components, 
but by introducing and analysing other attributes of the 
nodes composing the small world network, which are 
knowledge heterogeneity and geography. These are 
contingencies that affect knowledge sharing dynamics 
besides network structure.  
 
The research questions are the following: what is the 
impact of small world network structural characteristics on the 
cluster’s innovative performance in the pharmaceutical sector? 
How do contingencies, such as knowledge heterogeneity and 
geography, moderate the impact of a small world network 
structure on the cluster's innovation performance? 
3. Literature review 
 
3.1 Networks 
 
Studies that examine the consequences of networks1 
typically follow the structuralist perspective. This line of 
inquiry focuses on the configuration of ties, analysing 
how actors in networks influence each other’s attitudes 
and behaviours, and concluding that an actor’s payoff is a 
function of the network structure and of its position in the 
network. The literature suggests that a firm’s network of 
relationships influences its rate of innovation and R&D 
[16-18], often highlighting the benefits of networking. 
Networks allow knowledge sharing (knowledge, skills, 
physical assets) and knowledge flows (information 
conduits about technical breakthroughs and new 
insights) [16]. The greater the social capital possessed by 
the firm, the greater its knowledge will be, and therefore, 
the faster its innovation process [19]. 
 
Scholars supported competing schools of thoughts and 
two trade-offs are still in place: the first one is between 
the benefits of strong [20-21] versus weak [22] ties (that 
are likely to be bridges), the second one is between the 
benefits of disconnected network structures [23] versus 
dense network structures [24-25]. The question is whether 
network positions associated with the highest economic 
return lie between or within dense regions of 
relationships. Despite the considerable focus on the role 
of network structures in explaining firm performance 
outcomes, some researchers have acknowledged that a 
network of ties merely gives the focal firm the potential to 
access the resources of its contacts [26]. Contingencies 
need to be introduced, such as nodal heterogeneity [27]. 
 
3.2 Clusters and small world networks 
 
The concept of a network is more general than that of a 
cluster and does not necessarily entail local embedding, a 
shared objective, or a specific market [28]. The cluster 
concept has been defined in ambiguous ways. The full range 
of cluster definitions falls under two main lines of 
conception: (a) definition in reference [29]: “a geographically 
proximate group of inter-connected companies and 
associated institutions in a particular field, linked by 
commonalities and complementarities”, (b) definition in 
reference [30]: “networks of production of strongly 
interdependent firms, knowledge producing agents 
(universities, research institutes, engineering companies), 
bridging institutions (brokers, consultants) and customers, 
linked to each other in a value-adding production chain”, a 
mainly reticular conception of clusters. Contrary to the 
definition in reference [29], the approach of reference [30] is 
                                                                 
1 A form of organized economic activity that involves a set of 
nodes (e.g. individuals or organizations) linked by a set of 
relationships. 
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not very explicit on the issue of proximity, and it stresses the 
frequently localized but open nature of clusters: “in most 
cases they operate within localized geographical areas and 
interact within larger innovation systems at the regional, 
national and international level”. In the end there is no 
clarity on the geographical as well as on the sectoral 
characterization of clusters.  
 
A cluster - an aggregation of different players in a 
localized network [13] - has been better characterized by 
reference [31] in this way: "it comprises an ensemble of 
various organizations and institutions that are defined by 
respective geographic localizations occurring at variable spatial 
scales; that interact formally and/or informally through inter-
organizational and/or interpersonal regular or more occasional 
relationships and networks; that contribute collectively to the 
achievement of all kind of innovations within a given industry 
or domain of activity, i.e., within a domain defined by specific 
fields of knowledge, competences and technologies". As we can 
see, the concept involves a wide range of variation and 
even starting from this, it is possible to build around the 
type of organizations, the best spatial scale for 
geographical localization, the focus on a single domain, 
and the configuration of the network, as we do in this 
paper.  
 
In particular, we consider the impact of small world 
network structures, nodes' heterogeneity and nodes' 
geography on the innovation of clusters.  
 
The small world network phenomenon - i.e., the principle 
that we are all linked by short chains of acquaintances 
(commonly known as "six degrees of separation") - was 
introduced in the context of experimental studies in social 
sciences by reference [32] and since then it has been 
studied analytically in several network models. Among 
the most refined models there is the one by reference [15], 
the one we refer to. In this construction there is a local 
structure with a high density of integration in a wider 
random network and the coexistence of short-range and 
long-range connections (something that happens in many 
realistic networks, such as that of U.S. pharmaceutical 
clusters that we analyse). 
 
This reconciles the local properties of a regular network 
with the global properties of a random one, by 
introducing a certain amount of random long-range 
connections into an initially regular network [33], 
therefore the edges of the network are divided into "local'' 
and "long-range'' contacts. The authors argued that such a 
model captures two crucial parameters of social 
networks: there is a simple underlying structure that 
explains the presence of most edges, but a few edges are 
produced by a random process that does not respect this 
structure.  
 
This is useful in reconciling competing views in the 
literature on networks: the benefits of strong vs weak ties 
and of disconnected [23] vs dense [24] structures.  
 
The main characteristics of a small world network are the 
following: the overall network is numerically large; it is 
sparse in the sense that each node is connected to an 
average of only k other nodes n; it is decentralized in that 
there is no dominant central vertex to which most other 
networks are directly connected (not only the average 
degree k is much less that n but the maximum degree kmax 
over all the vertices must also be much less that n); it is 
highly clustered [34]. 
 
Since we are interested in the impact of small world 
networks on innovation, we refer to studies that analysed 
the effect of networks, and in particular of clusters, on 
innovation.  
 
Reference [35] showed that innovative research in 
biomedicine has its origins in regional clusters in the United 
States and in European nations. The success factors of a 
cluster have been identified with reference to the life-science 
industry as (a) proximity between university and research 
institutes and industry, with cross-fertilization and know-
how sharing; (b) access to human capital; (c) availability of 
infrastructures such as facilities and transportation; (d) 
cultural openness; (e) multidisciplinarity and spillovers, with 
interactions and synergies among disciplines; (f) 
development of fiscal and financial conditions supporting 
innovation.  
 
Clusters reflect the systemic character of modern interactive 
innovation, and therefore they are related to several 
conceptual frameworks and models developed under the 
literature on innovation systems. In this field, which 
emphasizes interactions among actors and innovation as a 
process embedded in a given social context, research has 
been carried out on sectoral systems [36], technology 
systems [37] and regional systems. The frameworks "mode 1, 
2 and 3" of knowledge production trace the evolution from 
the linear model of innovation to the interactive, non-linear 
model. We refer to "mode 3" of knowledge production, 
which advocates a system, consisting of innovation 
networks and knowledge clusters for knowledge creation, 
diffusion, and use [38]. This is a multilayered, multimodal, 
multinodal, and multilateral system, encompassing and 
reinforcing mutually complementary innovation networks 
and knowledge clusters characterized by the coexistence, 
coevolution, and cospecialization of different knowledge 
paradigms and different modes of knowledge production. 
 
This recall also the "Triple Helix" (TH) model of 
knowledge, developed by references [35-36], focused on 
three helices that intertwine and thus generate a national 
innovation system: academia/universities, industry, and 
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state/government. References [39-40] spoke of “university-
industry-government relations” and networks, also placing a 
particular emphasis on “tri-lateral networks” where those 
helices overlap and create synergies that result in product 
and process innovations. Strong, enterprise-supporting 
infrastructures complement strong, local science bases [41] 
challenging the conventional, linear model of interaction. 
Universities provide advanced research and a ready supply 
of human capital in the form of skilled graduates and basic 
research; companies provide real-world problems, 
commercialization opportunities, and funding. Innovative 
dedicated biotechnology firms (DBFs) seek to commercialize 
the results of the basic research; large pharmaceuticals 
provide funding, downstream marketing and distribution 
capabilities [42]); and governmental organizations provide 
user feedback and regulatory support.  
 
Many studies analysed the role of university−industry 
relationships in triggering new industrial R&D 
innovative projects [43] and found a positive impact [44-
45].  
 
4. Hypotheses development 
 
The aim of this paper is to study the concepts used to 
characterize the small world network, identify their connection 
with the cluster's innovation output, and complete the 
model with contingencies related to the nodes' 
characteristics.  
 
4.1 Small world network structure 
 
We refer to the small world network structure, a community of 
actors structured into well-defined clusters that are only 
sparsely connected to each other. 
 
We can deconstruct the small world network concept in the 
following elements: each cluster's density2; the presence of 
structural holes3 between one cluster and other clusters; and 
we can analyse its impact on innovation in the 
pharmaceutical industry. 
 
A dense innovative cluster provides benefits both from the 
learning and the governance perspective, favouring the 
exploitation4 of knowledge.  
                                                                 
2 Actual number of direct ties between nodes as a ratio of the 
maximum possible number of ties. 
3 A structural hole exists between the brokered actors, two nodes 
in a network, if the nodes share a tie with an individual but are 
not connected to each other [23]. Bridges between groups of 
nodes span structural holes with weak ties. 
4Exploitation (efficient employment of current asset and 
capabilities, implementation of the ideas discovered through 
exploration) and Exploration (discovery and development of novel 
ideas) and are both needed for the innovation outcome [46]. 
From the learning perspective, it facilitates the local 
transmission of information by providing numerous 
communication channels and pathways among actors, so 
that information introduced into a cluster will quickly 
reach other actors in it; it assures the future existence and 
relevance of different multiple sources of information; 
allows triangulation (i.e., by utilizing third parties to aid 
the judgment of knowledge and its absorption) [16,24]; 
facilitates intense interactions and knowledge integration 
[47]; improves the transfer of tacit, embedded knowledge 
[48-49]; enhances interfirm cooperation [47]; favours 
mutual understanding based on common norms or 
behaviours; increases the potential to build knowledge 
through intensive, repeated interactions and the exchange 
of ideas; and allows coordinated action. 
 
From a governance (TCE) perspective, it reduces 
transaction costs, allowing easier interactions between 
partners; reduces barriers to resource mobilization; 
reduces competitive practices; discourages misbehaviour, 
due to the so-called “shadow of the others” and “shadow 
of the future”; fosters a normative environment against 
opportunism; reduces risks; and engenders mutual trust, 
reciprocity norms, and shared identity, thus facilitating 
collaborative efforts by making the actors more willing to 
exchange information [16, 50]. 
 
On the other hand, the presence of structural holes allows 
the detection and the development of new ideas from 
remote parts of the network synthesized across 
disconnected pools of information, new opportunities, 
diverse experiences, and new understandings; the 
preservation of variety and heterogeneity, through the 
access to resources that are different from those found in 
an actor’s more immediate social network [22]; interfirm 
resource pooling [47]; flexibility; arbitrage opportunities 
for the brokering actors [51-53]; and novel combinations 
and re-combinations of ideas. These conditions favour the 
exploration component of innovation. 
 
In the end, while the presence of structural holes is suited 
to idea generation and invention, as it favours exploration 
and hampers implementation/action, a dense network 
structure is suited for idea implementation (coordinated 
action to implement ideas), as it favours exploitation but 
could potentially have an idea problem.  
 
The application of this debate to the pharmaceutical context 
and to the clusters can result in the following arguments.  
 
Some arguments suggest that the higher the density in the 
pharmaceutical cluster, the higher the cluster’s innovative 
performance.  
 
In fact, density is especially useful in the pharmaceutical 
industry because the innovation process, which is a 
complex sequence of stages, is a trial-and-error process, 
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with a lot of feedback loops and continuous shifts from 
exploration to exploitation as well as the opposite, which 
requires interaction. 
 
We could argue that in the specific context of the 
pharmaceutical industry, inside a single cluster the 
processes of exploration and exploitation are both in place. 
This is evident considering that biotech firms play an 
intermediary position, establishing exploration networks 
with universities and exploitation networks with 
pharmaceutical companies for commercialization [54]. 
However, in an exploration network of 
universities−biotech, reference [55] found high network 
density, high frequency of interaction, and high specific 
investment in mutual understanding. This is because we 
maintain that there is a fundamental difference between 
intra-cluster exploration and inter-cluster exploration. In the 
former, there is the involvement of the players in a 
common project that must have a specific innovative 
outcome, and not just the suggestions of ideas. So it is a 
finalized exploration process that will shortly result in 
exploitation and it is an exploration process that occurs in 
a prearranged systemic way.  
 
Therefore, inside a pharmaceutical cluster, in the cluster 
there is a finalized and structured exploration, a concept 
that is more similar to exploitation for certain 
characteristics, and for this reason the dense structure 
seems to accomplish both exploration and exploitation aims. 
In this way, we try to solve the debate between the two 
divergent views, that of reference [28] and that of 
references [22, 23] about the network structure more 
suitable for exploration and exploitation.  
 
Since we have varied players both inside and outside the 
clusters and usually exploration comes from variety, we 
have considered innovation as comprising inter-cluster 
exploration and intra-cluster exploration. Density is suitable 
for intra-cluster exploration while structural holes are good 
for inter-cluster exploration. Therefore, in order to spur 
inter-cluster exploration we could assert that the more the 
nodes in the pharmaceutical cluster span structural holes 
between the cluster and other clusters, the higher the cluster’s 
innovative performance.  
 
Due to different formation conditions and causes, clusters 
typically own heterogeneous knowledge that can migrate 
and be fruitfully recombined through links that span those 
clusters. 
 
Therefore, the presence of structural holes spanning between 
a cluster and other clusters (a configuration based on semi-
isolated subgroups) determines the extent to which the 
cluster’s knowledge base is continuously rejuvenated 
through knowledge inputs from outside the cluster [56] and 
novel combinations of ideas. 
While authors studying small world networks have usually 
focused on single organizations, suggesting that they can be 
broken into subgroups, semiautonomous subunits5, we 
focus instead on inter-cluster dynamics, where the 
subgroups are the single clusters and the organization can be 
all the clusters considered together.  
 
Therefore, we are considering an open cluster, where 
some members are engaged in relations with 
organizations belonging to other clusters, playing the role 
of the bridge [58]. This is a solution that tries to also join 
the conceptions of clusters of reference [29] and of 
reference [30], as explained in the literature review.  
 
Combining the organizational learning arguments with 
the small-world networks concept, we conclude that 
networks that have both clustering and some amount of 
linking between them, cluster-spanning bridges, spur 
each cluster innovation, striking the balance of exploration 
and exploitation.  
 
The bridging ties with other clusters allow for outside 
exploration through the possibility for any point in the 
network to benefit indirectly from the information or the 
knowledge received by his neighbour in other clusters 
[57], with the access to heterogeneous and novel ideas, while 
the high density of clusters allows for effective exploitation 
of ideas and inside cluster exploration. The benefits of local 
transmission and the information scope of cross-cluster 
connections can be simultaneously achieved.  
 
Dense and sparse configurations coexist at different scales 
and levels of the network, in a multiscaled cluster. Density 
comes from intra-cluster dynamics, while sparseness 
comes from inter-cluster dynamics, to assure the cluster 
life in the short as well as in the long term with the 
capability of catching new ideas from outside and of 
effectively implementing them inside the cluster in wider 
innovation oriented networks. 
 
Closure allows us to realize the value buried in a structural 
hole, effectively implementing the new ideas obtained from 
outside inside the cluster [59]. 
 
This means that the more the nodes in the pharmaceutical cluster 
span structural holes between the cluster and other clusters, the 
higher the positive impact of density will be in the life-science 
cluster on the cluster’s innovative performance.  
 
Therefore, in sum, we can formulate the following 
hypothesis: 
 
                                                                 
5 The whole firm could be studied as a smallworld network and 
the workgroups could be considered as clusters interacting with 
one another [57].
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HP1: The more the pharmaceutical cluster is integrated in a 
small world network structure, the higher the cluster's 
innovative performance.  
 
4.2 Contingencies 
 
Although the solution of combining density in the intra-
cluster dimension and brokerage in the inter-cluster 
dimension is undoubtedly conceptually attractive, it 
appears likely that its impact on innovation will be 
contingent on several elements. We focus on two relative 
properties of the nodes as contingencies: partner 
heterogeneity and geography.  
 
4.2.1 Heterogeneity 
 
Pharmaceutical clusters comprise different actors, which 
occupy different positions in the supply value chain, from 
downstream to upstream: pharmaceutical, biotech firms, 
universities, research institutes, institutions. From the 
"Triple Helix" Model of knowledge [39-40], we know that 
when three helices (universities, industry, and 
government) intertwine, through relations and networks, 
they overlap and create synergies that result in product 
and process innovations. Universities provide advanced 
research and human capital; companies, real-world 
problems, commercialization opportunities; institutions, 
user feedback and regulatory support.  
 
This system provides a broader view of the value chain 
and interaction between private and public actors in 
innovative R&D activities [60]. 
 
However, diversity can represent both an opportunity 
(novelty value), favouring knowledge development, and 
a problem (reduced absorptive capacity, higher 
transaction costs), disfavouring knowledge transfer [28].  
 
The impact of heterogeneity on innovation appears 
different in the local (intra-cluster) and long-range (inter-
cluster) setting of the small world network.  
 
On one side, in the local, intra-cluster setting of the small 
world network, vertical diversity6 has a positive 
moderation effect. It enhances the internal exploration 
process, favouring Schumpeterian “novel combinations”, 
                                                                 
6 Vertical diversity can be defined as the cognitive distance and 
differences in alliance partners’ operational contexts in the value 
chain, it implies a distinction among three categories: horizontal, 
upstream, or downstream [61]. For instance a biotech and a 
pharmaceutical firm are diverse, two pharmaceutical firms are 
equal. Vertical diversity in the intra-cluster setting is the range 
of diverse partners - number of diverse partners inside the 
cluster. In the inter-cluster setting it is measured for pairs of 
nodes (the extremes of the structural hole). 
while the problem of the absorptive capacity7 is 
counterbalanced by the presence of high connectivity in 
the cluster.  
 
Reference [62] argued that it is the preservation of diverse 
ideas within sub-groups (i.e., single clusters) that increases 
the information scope of the overall network and 
consequently the innovation output of the single cluster. 
 
Moreover, vertical diversity allows the effectiveness of 
the exploitation process that in the life-science industry 
requires complementary skills and the appropriate 
division of labour. A final argument is that redundancy in 
a dense network discourages idea generation; this 
redundancy will be reduced in the presence of the 
vertical diversity of nodes. 
 
Considering the context of the pharmaceutical industry, 
we can point out some additional remarks. First, partner 
diversity is really important to answering the regulatory 
requirements. The life-science R&D process is scheduled 
as a strict sequence of different stages that will be better 
performed if they involve different specialized players, 
covering different roles and responsibilities. Moreover, 
diversity will better allow feedback loops and support a 
trial-and-error sequence, typical of life-science industry 
R&D [63]. Second, vertical diversity in this industry 
means also complementarity. Therefore, a cluster high in 
vertical diversity implies that firms may specialize in 
either exploitation or exploration, and seek the other 
through relations with other organizations with 
complementary specialization. Furthermore, in the 
literature, arguments have been made that when firms 
combine complementary skills, greater innovation results 
[64]. If partners’ vertical diversity implies 
complementarity, which in turn implies innovation, 
partners’ vertical diversity drives innovation.  
 
Therefore, the nodes’ vertical diversity in the pharmaceutical 
cluster positively moderates the impact of density on the 
cluster’s innovative performance. The higher the level of 
nodes’ vertical diversity in the cluster, the higher the 
positive impact of density on the cluster’s innovative 
performance.  
 
On the other side, in the long-range, inter-cluster setting 
of the small world network, the link connecting cluster to 
cluster should be a weak tie in a sparse configuration, and 
the problem of absorptive capacity between the two 
extreme nodes is higher than in the intra-cluster case.  
 
It is true that partner diversity in the pharmaceutical 
industry involves a related knowledge background: 
players act in subsequent phases of the same macro-
                                                                 
7 The ability to recognize, assimilate, and apply external knowledge. 
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process, and thus it is possible to suppose that they have 
the same background in terms of basic skills, shared 
language, and knowledge of the most recent scientific or 
technological developments; techno-organizational 
systems (TOS), molecules, and drugs [65]. This reduces 
the concern of an absence of absorptive capacity. 
 
However, in any case, if learning performance from 
interaction is the mathematical product of novelty value 
and understandability, the result is an inverted-U shaped 
relation with cognitive distance. Optimal cognitive 
distance lies at the maximum of the curve where there is a 
sustainable level of transaction costs and competition, 
and a good level of complementarity and absorptive 
capacity.  
 
Therefore, the vertical diversity between the two nodes 
spanning an inter-cluster structural hole moderates the impact 
of the inter-cluster structural hole on the cluster’s innovative 
performance with an inverted U-shaped pattern. 
 
A moderate level of vertical diversity between the two 
nodes spanning the inter-cluster structural hole enhances 
the positive impact of the inter-cluster structural hole on 
the cluster’s innovative performance; while a level that is 
too low or too high reduces this impact.  
 
Finally, we can state the following hypothesis:  
 
HP2: The nodal vertical diversity moderates the impact 
of the integration of the cluster in a small world network 
structure on the cluster's innovative performance. 
 
4.2.2 Geography 
 
In the literature some elements support localization and 
proximity for innovation, others a wider geographical 
extension. 
 
Factors supporting geographical proximity are: 
transaction costs reduction and development of relational 
dimensions; location-specific drug development for 
epidemiological reasons; location-specific regulatory 
framework; tacit knowledge transfer, frequency of 
interaction, trust; location-specific assets (agglomeration 
economies, pool of skilled labour; scientific, commercial 
spillovers) in positive externality arenas. Moreover, the 
theory of proximity in the network theory identifies 
proximity as the main facilitator of knowledge flows [66]. 
Factors supporting geographical distance are: the need 
for an escape from local embedding for innovation; 
embedding in virtual communities, with internet use 
reducing transaction costs; the substitutive role of 
frequent meetings; the avoidance of the lock-in effect 
(social legitimacy; institutional embedding: local 
obligations); tension toward trans-local, disembedded 
clusters, in the real world and in institutional 
recommendations (e.g., the European Commission) to 
enhance competitiveness. 
 
Clusters of which all individual elements are to be found 
in a confined area are the exception rather than the rule. 
Especially in some industries, it might even be 
counterintuitive to expect “complete” clusters at the 
regional or national level, as the relevant knowledge base 
is strongly dispersed, as in the pharmaceutical industry.  
 
For instance, drug companies are beginning to invest in 
Chinese R&D; in fact, the Chinese market may become 
the second-biggest pharmaceuticals market in the world 
by 2020. Recent studies show that the famous Italian 
industrial districts are facing a crisis [67]. In order to 
survive they are becoming locally disembedded, shifting 
some activities, especially in production, outside the local 
environment [68]. 
 
Therefore, a better solution for innovation would be a 
balance between local and non-local players in the small 
world network, both inside the cluster and in the inter-
cluster connections: the shared context of a local circuit 
and of remote cooperation will be complementary 
resources [13], favouring the combination of exploration 
and exploitation. A moderate level of geographical 
distance will enhance the positive impact of density and 
structural holes on a cluster’s innovative performance.  
 
Therefore, we can presume that the geographical distance 
between the nodes in the pharmaceutical cluster moderates the 
impact of density on the cluster’s innovative performance with 
an inverted U-shaped pattern and similarly the geographical 
distance between the two nodes spanning an inter-cluster 
structural hole moderates the impact of the inter-cluster 
structural hole on the cluster’s innovative performance with an 
inverted U-shaped pattern.  
 
This means that a moderate level of geographic distance 
between the nodes in the life-science cluster enhances the 
positive impact of density; while a level that is too low or 
too high reduces this impact. Similarly, a moderate level 
of geographic distance between two nodes spanning an 
inter-cluster structural hole enhances the positive impact 
of the inter-cluster structural hole on the cluster’s 
innovative performance; while a level that is too low or 
too high reduces this impact. 
 
Finally, we can state the following hypothesis: 
 
HP3: The nodal geographical distance moderates the 
impact of the integration of the cluster in a small world 
network structure on the cluster's innovative 
performance.  
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5. Analysis  
 
5.1 Sample and data collection 
 
We explored the arguments mentioned in the previous 
sections by using a social network approach and a 
regression model applied to the U.S. pharmaceutical 
industry.  
 
We built a sample including eight pharmaceutical 
clusters in the U.S. and their firms, which are industrial, 
academic and institutional organizations.  
 
To obtain the final sample, the following procedure was 
followed. First, a list of all the pharmaceutical clusters 
established in the U.S. was drawn up using the U.S. Cluster 
Mapping Database8. 
 
We retrieved the list of clusters for four years: 2007, 2008, 
2009, 2010. Second, we identified the nodes composing 
each cluster (firms, institutions etc.) through 
complementary sources: U.S. Cluster Mapping Database, 
websites, online libraries, newspapers, archival data 
(official documents, previous studies on clusters). Then, we 
executed a standardization of the names. Subsequently, we 
excluded from the sample a few clusters for which data 
were not available.  
 
The minimum number of nodes in the clusters is 92, the 
maximum 645. The final sample includes the following 
eight clusters (CL): CL1: Life Science Alley; CL2: 
Massachusetts Biotechnology Council; CL3: Oregon 
Bioscience Association, CL4: BIOCOM; CL5: Arizona 
Bioindustry Association; CL6: Nashville Health Care 
Council; CL7: North Carolina Biotechnology Center; CL8: 
Connecticut United for Research Excellence, Inc. The 
number of nodes composing each cluster is respectively: 
645 in CL1, 590 in CL2, 167 in CL3, 546 in CL4, 232 in CL5, 
257 in CL6, 595 in CL7, 92 in CL8.  
 
In order to build our dependent variable, we collected 
patent data for each cluster from the U.S. Cluster Mapping 
Database. We filtered the patent data according to the year 
and the industry of interest. Afterwards, for the 
independent and control variables we collected attribute 
and relational data. 
 
As for the attributes, we considered: a) the nodal 
characteristics: for each node in the clusters we identified 
the type of organization, i.e., the role in the vertical chain, 
and the geographical location. We obtained different 
categories for the firm type (e.g., biotechnology, 
pharmaceutical, academic institution etc.) and the states 
                                                                 
8 From Harvard Business School, a project funded by the U.S. 
Department of Commerce, Economic Development Administration. 
in which the firms are located. We used the sources 
mentioned above; b) the cluster's characteristics: the 
number of employees and the cluster's specialization 
(from U.S. Cluster Mapping Database). 
 
As for the relational data, we collected all the transactions 
and agreements between the nodes of the cluster related to 
research and development, and distinguished short-range 
intra-cluster from long-range inter-cluster ties.  
 
Intra-cluster ties are ties between the nodes belonging to the 
same cluster, while inter-cluster ties are ties between nodes 
belonging to different clusters. One node can be 
simultaneously in different clusters and this is another case 
of an inter-cluster tie (even if the tie will occur between two 
divisions of the same firm).  
 
To retrieve these data we combined the sources mentioned 
before with the SDC Platinum database, produced by 
Thomson Reuters, specifically the Joint Venture/Strategic 
Alliances section that provides substantial archival 
information on inter-firm agreements, and represents one 
of the most comprehensive and reliable sources used in 
alliance research [69-70]. Since the focus is on the impact of 
the ties on a firm's innovative performance, we filtered the 
output to keep just the alliances of selected types, namely 
R&D agreements and manufacturing agreements. Thus, we 
built the networks using the UCINET VI program [71]: the 
network of each cluster and the inter-cluster network.  
 
In figure 1, the long-range, inter-cluster ties are 
summarized: each of the eight clusters is connected to 
external clusters through the linkages of its nodes to other 
clusters' nodes; the thickness of the segment represents 
the strength of the connection as a function of the number 
of ties.  
 
 
Figure 1. Long-range, inter-cluster ties 
 
In this way we reconstructed both the whole network and 
the single sub-units of the network, which are clusters.  
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Finally, we adopted a social network analysis (SNA) and we 
computed the network variables with a full network 
method aimed at identifying network characteristics and 
actors’ positions. We applied procedures which can be 
used to study networks of networks, composed of many 
types of organizations. The results show that, in general, 
clusters have a high density inside the cluster, and many 
structural holes between different clusters. Therefore, the 
setting is suitable for testing the small world network 
impact.  
 
5.2 The model 
 
Traditional estimations of the effects that network 
variables have on the innovation of a cluster are carried 
out with a regression model. The regression equation can 
be written as follows, using a pooled cross-sectional 
notation9:  
 
C Patents it= 
ß0+ß1(C_Density)it-n+ß2(Inter-C_SH)it-n+ß3(C_Density)*(Inter-
C_SH)it-n+ ß4(N_Vertical_Heterogeneity)it-n+ß5(N_Vertical_ 
Heterogeneity)*(C_Density)it-n+ ß6(N_Vertical_ 
Heterogeneity)*(Inter-C_SH)it-n+ß7(N_Geogr.Dist)+ 
ß8(N_Geogr.Dist)*(C_Density)it-n+ß9(N_Geogr.Dist)*(Inter-
C_SH)it-n+ß10(controls)it-n+εit-n 
 
where C: Cluster's, N: nodes', SH: structural holes. 
 
We used a time-lag of one year between the dependent 
variable and the regressor values: the dependent variable 
is computed at time t, while all the regressors are 
computed at time t-1. 
 
The dependent variable, cluster's innovation performance 
measured through the number of patents, is a variable that 
takes only non-negative integer values. Since the 
assumption of the linear regression model of 
homoskedastic normally distributed errors is violated, a 
count model should be used. Poisson regression is the 
standard or base count response regression model [72]. We 
considered six statistical specifications, following reference 
[73] who explained panel models for counting data, 
mentioning four panel Poisson estimators - pooled Poisson 
with cluster-robust errors, population-averaged Poisson, 
Poisson random effects (RE), and fixed effects (FE) and 
Negative binomial models RE and FE. We finally choose 
pooled Poisson with cluster-robust errors following reference 
[73] who asserted that in the use of the pooled Poisson 
model, getting cluster-robust standard errors with clusters 
on individuals (i) has the effect of controlling for both 
overdispersion and correlation overtime for a given i. The 
authors provided an example, showing that with respect to 
                                                                 
9 We use a longitudinal research design and therefore all the 
variables are indexed over firms (i) and over time (t). 
the default non-cluster-robust, the default standard errors 
are one-fourth as large and that the default t-statistics are 
four times as large. We also checked the need to use 
negative binomial models, but this was not supported by 
the value of the dispersion parameter α. 
 
5.3 Variables and measures 
 
The dependent variable is the cluster's innovation output, 
measured through patents counts: the number of patents 
granted for a cluster i in a given year t.  
 
The independent variables are the following: (1) small 
world network characteristics, which are expressed by (1.1) 
intra-cluster density: the number of the effective ties 
divided by the number of possible ties in the cluster, i.e., 
L/[n(n-1)/2], where L is the number of the effective ties; 
(1.2) inter-cluster spanning of structural holes (SH): number 
of linkages of a cluster with external clusters, through its 
nodes that span structural holes between clusters; (2) 
intra-cluster vertical heterogeneity: number of different firm 
types for each cluster. This is measured using an index 
similar to the Berry–Herfindahl Index. It is calculated by 
squaring the weight of each firm type in a cluster (in 
terms of the number of firms of that category by the total 
number of firms in the cluster) and then summing the 
resulting numbers. The index is equal to 1 minus this 
sum. The index takes into account the relative size 
distribution of the firm types in a cluster. It approaches 
zero when a cluster is controlled by a single firm type and 
reaches its maximum when a cluster is occupied by a 
large number of firm types of relatively equal size 
(number of firms). The effect of the measure is to not take 
into account the firm types that are marginal. (3) Inter-
cluster vertical heterogeneity: the ratio of the firm types in 
the external clusters are different from the firm types 
inside the cluster (which the cluster reaches through 
inter-cluster ties) to the internal firm types. Firm types are 
weighted by the number of firms in each firm type; (4) 
intra-cluster geographical distance: the weighted sum of all 
the distances of the node's locations from the cluster's 
main area (the majority of the nodes composing a cluster 
are located in the same state). The weight is given by the 
number of firms in the same location; (5) inter-cluster 
geographical distance: the weighted sum of the distances of 
a cluster from all the external clusters to which it is 
connected through inter-cluster ties. The weight is given 
by the number of inter-cluster ties; (8) interaction terms: 
mathematical products of the above mentioned variables. 
 
The control variables are: empshare: share of national 
employment for each cluster; cluster specialization: level of 
concentration of employment in specific clusters; intra-
cluster size: number of nodes in the cluster; R&D ratio: 
R&D expenses / Operating revenue. These are retrieved 
from the U.S. Cluster Mapping Database.  
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Empshare, cluster specialization and intra-cluster size were 
retrieved from the U.S. Cluster Mapping Database; R&D 
ratio, was found by collecting data from the Osiris 
Database from the balance sheets of the companies 
composing the clusters (compatibly with their 
availability) and computing the mean inside each cluster.  
 
5.4 Results 
 
The regression was implemented on eight clusters, with 
32 observations over the four years analysed.  
 
As Table 1 shows, the results support the hypotheses, and 
the mechanisms referring to the impact of small world 
network characteristics and contingencies on innovation 
are confirmed. 
 
Hypothesis 1 investigated the impact of the small world 
network structural characteristics on the cluster's 
innovation output. Hypothesis 1 referred to the 
combination (interaction) of the two main components of 
small worlds: density and the spanning of structural holes, 
and predicted that the integration of the short-range 
clustering and the long-range reach would have a 
positive impact on the cluster's innovative output. The 
hypothesis is supported, being the resulting coefficient 
positive and significant at level p < 0,01.  
 
The effect of each of the components taken individually is 
the same as the effect of the interaction term. As for the 
short-range intra-cluster ties, the cluster density is 
associated with the superior cluster's innovative output. 
In fact, the resulting coefficient of the variable intra-cluster 
density is positive and significant at a level of p < 0,05. 
 
As for the long-range, inter-cluster setting the inter-
cluster spanning of structural holes is associated to a 
greater cluster’s innovative output. In fact the resulting 
coefficient of the variable inter-cluster spanning of SH is 
positive and significant at a level of p < 0,05. 
 
Two moderation effects, related to nodal characteristics, 
were predicted as being likely to intervene in this process, 
introducing a contingent approach in the small world 
network setting.  
 
The first effect involves nodes' vertical heterogeneity and 
corresponds to Hypothesis 2. 
 
Hypothesis 2 predicted two effects.  
 
First, that the intra-cluster vertical heterogeneity would 
positively moderate the main effects presented in 
Hypotheses 1 regarding density. The hypothesis is tested 
with the interaction terms (intra-cluster vertical 
heterogeneity * intra-cluster density) and is supported by a 
coefficient that is positive and significant at a level of p < 
0,001. Therefore, the higher the intra-cluster vertical 
heterogeneity, the higher the positive impact of the intra-
cluster density on the cluster's innovation output.  
 
Second, it predicted that the inter-cluster vertical 
heterogeneity would moderate the main effects presented 
in Hypothesis 1 regarding the spanning of structural 
holes, with an inverted U-shaped pattern. The hypothesis 
is tested with an interaction term and with its square 
(inter-cluster vertical heterogeneity* inter-cluster spanning of 
SH; squared). The hypothesis found strong support, with a 
positive coefficient for the interaction term and a negative 
coefficient for the square, which are both highly 
significant at a level of p < 0.001. Therefore, a moderate 
level of inter-cluster vertical heterogeneity would 
emphasize the positive impact of the inter-cluster 
spanning of structural holes on the cluster's innovation 
output. 
 
The second moderation effect involves nodes' 
geographical distance and corresponds to Hypothesis 3. 
 
Hypothesis 3 predicted two effects.  
 
First, that the intra-cluster geographical distance would 
moderate the main effects presented in Hypotheses 1 
with an inverted U-shaped pattern. The hypothesis found 
strong support, with a positive coefficient for the 
interaction term (Intra-cluster Geographical Distance * Intra-
cluster Density) and a negative coefficient for the square, 
that are highly significant at a level of p < 0.001. 
 
Second, it was hypothesized that the inter-cluster 
geographical distance would moderate the main effects 
presented in Hypotheses 1 with an inverted U-shaped 
pattern. The hypothesis found strong support, with a 
positive coefficient for the interaction term (inter-cluster 
geographical distance * inter-cluster spanning of SH) and a 
negative coefficient for the square, which are highly 
significant at a level of p < 0.001. In sum, a moderate level 
of geographical distance, would emphasize the positive 
impact of density on the cluster's innovation output, in 
the intra-cluster setting, and of the inter-cluster spanning 
of structural holes on the cluster's innovation output, in 
the inter-cluster setting. In conclusion, the theoretical 
framework is supported by the data.  
 
As for the control variables in the full model, empshare is 
negative and significant at a level of p<0,001, size intra-
cluster is positive and significant at a level of p<0,001, 
cluster specialization and R&D ratio are not significant.  
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6. Discussion and conclusions  
 
The main contribution and results of the study are a 
framework that suggests an understanding of the factors 
that give rise to differential innovative outcomes across 
different clusters, by using a network approach. In 
particular we tried to hypothesize the impact of a cluster's 
small world network structural characteristics as well as of 
nodal characteristics on the cluster's innovative 
performance.  
 
By using the concept of small worlds, we tried to 
distinguish between intra-cluster and inter-cluster 
dynamics in line with the conception of cluster in 
reference [30] as mainly open and reticular. Then, the 
potential moderation effect of contingency factors on the 
relations between small world network structure and 
cluster innovative performance were underlined. 
 
 
* p<0,05 ; ** p<0,01; *** p<0,001. Standard errors are in  
parenthesis  
 
However, one limitation of the study is the low level of 
external validity with respect to the setting. We articulated 
our conceptual framework with respect to the clusters in 
the pharmaceutical industry in which trends of increased 
specialization, enhanced regulatory hurdles, and growing 
systemic complexity have clearly emerged over the last 
decades. The advent of molecular biology and genetic 
engineering yielded a profound transformation of the 
industry and induced a new division of labour that 
required a new organizational form made up of new 
networks of scientists, specialized new entrants and large 
pharma firms. The predictions could be hardly applied to 
other contexts. 
 
Finally, the work could be further improved from an 
empirical point of view by enriching the model with more 
control variables, like the financials of the nodes 
composing the clusters (e.g., ROA, current ratio, debt to 
equity etc.). 
 
The results provide a test of the impact of a small world 
network structure on innovation outcomes, thus 
increasing the managerial capabilities with reference to 
the choice of the best structural configuration and partner 
mix in cluster formation.  
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